Frontier Investment Management’s Elevance Health ELV Stock Holding History

Frontier Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,443	Closed	-$2.36M	–	203
2016 Q4	$2.36M	Sell	16,443 -920	-5%	-$123K	0.22%	87
2016 Q3	$2.18M	Sell	17,363 -205	-1%	-$26.5K	0.19%	80
2016 Q2	$2.31M	Sell	17,568 -665	-4%	-$91K	0.29%	80
2016 Q1	$2.53M	Sell	18,233 -1,390	-7%	-$186K	0.34%	70
2015 Q4	$2.74M	Sell	19,623 -880	-4%	-$121K	0.43%	55
2015 Q3	$2.87M	Sell	20,503 -11,410	-36%	-$1.71M	0.48%	56
2015 Q2	$5.24M	Sell	31,913 -360	-1%	-$57.5K	0.61%	44
2015 Q1	$4.87M	Sell	32,273 -1,187	-4%	-$169K	0.69%	39
2014 Q4	$4.2M	Sell	33,460 -2,005	-6%	-$248K	0.71%	36
2014 Q3	$4.24M	Buy	+35,465	New	+$4.07M	0.68%	41

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Frontier Investment Management's ELV Position: Q1 2017 in Review

Frontier Investment Management sold out of Elevance Health (ELV) in Q1 2017, closing a stake of 16,443 shares — an estimated $2.36M sold.

Frontier Investment Management first reported a position in ELV in Q3 2014 and held it in 10 quarters. The position peaked at $5.24M in Q2 2015. 796 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

Frontier Investment Management reported no remaining Elevance Health position as of Q1 2017 after selling out during the quarter.
Frontier Investment Management sold 16,443 Elevance Health shares in Q1 2017, an estimated $2.36M.
Frontier Investment Management first reported a position in Elevance Health in Q3 2014 and held it in 10 quarters.
Frontier Investment Management's Elevance Health position peaked at $5.24M in Q2 2015.
796 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on Frontier Investment Management's 13F filing for Q1 2017, filed 12 May 2017.